Kuveda provides oncologists with SaaS-based tools and services for the analysis of cancer patients’ molecular profiles to derive personalized therapeutic cancer treatment options. Its patent pending network analysis engine enables oncologists to identify treatment options based on bio-markers, proteins, genes, pathways, specific molecules, and more. It also utilizes curated repositories daily to obtain relevant pharmacological, biological, toxicological, and genetic information to give oncologists comprehensive reports. Kuveda offers oncologists with patient specific drug regiment options, supporting evidence and insights, individual patient biology, patient history, and toxicology considerations. Kuveda is a part of the StartUp Health Academy, a global long-term coaching program and peer network for healthcare entrepreneurs. It has a global peer network of healthcare innovators in seven countries and 45 cities. Kuveda is based in California, United States.

Kuveda provides oncologists with SaaS-based tools and services for the analysis of cancer patients’ molecular profiles to derive personalized therapeutic cancer treatment options. Its patent pending network analysis engine enables oncologists to identify treatment options based on bio-markers, proteins, genes, pathways, specific molecules, and more. It also utilizes curated repositories daily to obtain relevant pharmacological, biological, toxicological, and genetic information to give oncologists comprehensive reports. Kuveda offers oncologists with patient specific drug regiment options, supporting evidence and insights, individual patient biology, patient history, and toxicology considerations. Kuveda is a part of the StartUp Health Academy, a global long-term coaching program and peer network for healthcare entrepreneurs. It has a global peer network of healthcare innovators in seven countries and 45 cities. Kuveda is based in California, United States.

Cellanyx is a biotechnology company specializing in cancer diagnostics, prognostics, cell-based assays, and pharmaceuticals for epithelial-born cancers. They are advancing proprietary phenotypic biomarker tests based on Machine Vision and AI analysis o...

Cellanyx is a biotechnology company specializing in cancer diagnostics, prognostics, cell-based assays, and pharmaceuticals for epithelial-born cancers. They are advancing proprietary phenotypic biomarker tests based on Machine Vision and AI analysis o...